phenylephrine hydrochloride; tropicamide · Eyenovia · NDA 215352
Mydcombi
Earliest generic entry, as listed
15 Jul 2031
No marketed reference-listed strength; date taken from all listed strengths.
Blocked by patent: US 10839960, US 11398306, US 11839487. Only method-of-use patents remain, so a generic may carve out the protected indication and enter earlier.
Listed patents · 3 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 10839960 | use U-3685 | 15 Jul 2031 |
| US 11398306 | use U-3685 | 15 Jul 2031 |
| US 11839487 | use U-3685 | 15 Jul 2031 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 215352 · 001 · RLD · discontinued | spray, metered, ophthalmic | 2.5%;1% | 15 Jul 2031 |
Expired or delisted (1)
- NP · 5 May 2026